running shoes on., page-7

In the relatively near future (as announced), Neuren
have completion of the Phase I, initiation of the Phase II in mTBI, initiation of the Phase II in Rett Syndrome, presentation at the Arrowhead TBI conference, etc. Neuren also will have granting of Orphan Drug and Fast
Track designation for the Rett program (not announced but should be obvious). Somewhere in between all that, I imagine they'll announce results from the in vivo screening of the Perseis antibodies (yes, it's a little behind schedule but that's the way science is sometimes).

Plenty of news to keep things moving short term.

Tony